• OPEN AN ACCOUNT
Indian Indices
Nifty
19,674.25 -68.10
(-0.34%)
Sensex
66,009.15 -221.09
( -0.33%)
Bank Nifty
44,612.05 -11.80
( -0.03%)
Nifty IT
32,906.30 -13.65
( -0.04%)
Global Indices
Nasdaq
13,211.81 -12.18
(-0.09%)
Dow Jones
33,963.84 -106.58
(-0.31%)
Hang Seng
18,057.45 402.04
(2.28%)
Nikkei 225
32,402.41 -168.62
(-0.52%)
Forex
USD-INR
83.11 0.01
(0.01%)
EUR-INR
88.51 -0.32
(-0.36%)
GBP-INR
102.21 -0.61
(-0.59%)
JPY-INR
0.56 0.00
(0.01%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
305.1850625
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
34.97
95796.29
EPS(TTM)
Face Value()
Div & Yield %
33.93
2
0.72
 

cipla ltd
Cipla to divest its entire 51% stake in Saba Investment, UAE
May 16,2023
Cipla has entered into a binding term sheet to sell its entire stake of 51% held in Saba Investment, UAE (Saba) to Shibam Group Holding, UAE.

Consequent to the sale, upon executionof the transaction, Saba and its subsidiaries viz Cipla Middle East Pharmaceuticals FZ LLC, UAE (CME) and Cipla Medica Pharmaceutical and Chemical Industries, Yemen (Cipla Medica), will cease to be subsidiaries of the Company.